Elevated Inflammatory Burden Index Increases Mortality in Adults with Chronic Inflammatory Airway Diseases: a Nationwide Cohort Study

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2024 Aug 20

PMID 39164650

Authors

Ning Zhu

Shanhong Lin

Linfeng Wang

Xue Kong

Weina Huang

Chao Cao

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to investigate the potential association between the inflammatory burden index (IBI) and the prevalence of chronic inflammatory airway diseases (CIAD), as well as mortality rates among individuals diagnosed with CIAD.

Methods: Participants were sourced from the National Health and Nutrition Examination Survey (NHANES) conducted between 1999 and 2010. The IBI was calculated using the formula: IBI = C-reactive protein * neutrophils / lymphocytes. CIAD comprised self-reported asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). Mortality outcomes, including all-cause and respiratory disease mortality, were determined through linked data from the National Death Index (NDI) up to December 2019.

Results: A total of 27,495 adults were included. IBI was divided into quartiles, with the lowest quartile as the reference group. After adjusting for confounding variables, a positive correlation was observed between higher IBI and increased prevalence of total CIAD (OR = 1.383 [1.215-1.575]), asthma (OR = 1.267 [1.096-1.465]), chronic bronchitis (OR = 1.568 [1.263-1.946]), and COPD (OR = 1.907 [1.311-2.774]). Over a median follow-up of 12.33 [9.92-16.00] years, there were 1221 deaths from all causes and 220 deaths from respiratory disease among 4499 patients with CIAD. Following multivariate adjustments, the fourth quartile was significantly associated with increased risk of all-cause mortality (HR = 2.227 [1.714-2.893]) and respiratory disease mortality (HR = 2.748 [1.383-5.459]) compared to the first quartile of IBI in CIAD participants. Moreover, variable importance analysis using a random survival forest model demonstrated the significance of IBI in predicting mortality from both all-cause and respiratory diseases.

Conclusion: IBI exhibited an association with the prevalence of CIAD, with higher IBI levels correlating with elevated all-cause and respiratory disease mortality among individuals with CIAD.

Citing Articles

Association between oxidative balance score and all-cause, CVD and respiratory-related mortality in the US older adults of asthma patients with diabetes.

Liu C, Liang D, Xiang G, Zhao X, Xiao K, Xie L Front Nutr. 2025; 11:1519570.

PMID: 39882043 PMC: 11775759. DOI: 10.3389/fnut.2024.1519570.

References

. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585-596. PMC: 7284317. DOI: 10.1016/S2213-2600(20)30105-3. View

Aksu F, Capan N, Aksu K, Ofluoglu R, Canbakan S, Yavuz B . C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013; 5(4):414-21. PMC: 3755654. DOI: 10.3978/j.issn.2072-1439.2013.06.27. View

Huang W, Huang G, Zhan Q, Chen J, Luo W, Wu L . The neutrophil to lymphocyte ratio as a novel predictor of asthma and its exacerbation: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2020; 24(22):11719-11728. DOI: 10.26355/eurrev_202011_23819. View

Miller R, Grayson M, Strothman K . Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management. J Allergy Clin Immunol. 2021; 148(6):1430-1441. DOI: 10.1016/j.jaci.2021.10.001. View

Xie H, Ruan G, Ge Y, Zhang Q, Zhang H, Lin S . Inflammatory burden as a prognostic biomarker for cancer. Clin Nutr. 2022; 41(6):1236-1243. DOI: 10.1016/j.clnu.2022.04.019. View

Pelc Z, Sedlak K, Mlak R, Lesniewska M, Mielniczek K, Rola P . Prognostic Value of Inflammatory Burden Index in Advanced Gastric Cancer Patients Undergoing Multimodal Treatment. Cancers (Basel). 2024; 16(4). PMC: 10886992. DOI: 10.3390/cancers16040828. View

He C, Wu D, Wei X, Li Y, Liao Y, Yang D . Association between inflammatory burden index and all-cause mortality in the general population aged over 45 years: Data from NHANES 2005-2017. Nutr Metab Cardiovasc Dis. 2023; 34(1):64-74. DOI: 10.1016/j.numecd.2023.10.006. View

Fahy J . Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol. 2014; 15(1):57-65. PMC: 4390063. DOI: 10.1038/nri3786. View

Razi E, Ehteram H, Akbari H, Chavoshi V, Razi A . Evaluation of high-sensitivity C-reactive protein in acute asthma. Tanaffos. 2014; 11(1):32-7. PMC: 4153180. View

10.

Aghasafari P, George U, Pidaparti R . A review of inflammatory mechanism in airway diseases. Inflamm Res. 2018; 68(1):59-74. DOI: 10.1007/s00011-018-1191-2. View

11.

Donaldson G, Seemungal T, Patel I, Bhowmik A, Wilkinson T, Hurst J . Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005; 128(4):1995-2004. PMC: 7172405. DOI: 10.1378/chest.128.4.1995. View

12.

Ke J, Qiu F, Fan W, Wei S . Associations of complete blood cell count-derived inflammatory biomarkers with asthma and mortality in adults: a population-based study. Front Immunol. 2023; 14:1205687. PMC: 10416440. DOI: 10.3389/fimmu.2023.1205687. View

13.

Sorensen A, Holmgaard D, Mygind L, Johansen J, Pedersen C . Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study. J Inflamm (Lond). 2015; 12:20. PMC: 4407303. DOI: 10.1186/s12950-015-0064-5. View

14.

Dharmage S, Perret J, Custovic A . Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019; 7:246. PMC: 6591438. DOI: 10.3389/fped.2019.00246. View

15.

Zhou G . Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer. Cancer Biol Med. 2020; 16(4):700-713. PMC: 6936241. DOI: 10.20892/j.issn.2095-3941.2019.0180. View

16.

Dong L, Liu Z, Chen K, Li Z, Zhou J, Shen H . The persistent inflammation in COPD: is autoimmunity the core mechanism?. Eur Respir Rev. 2024; 33(171). PMC: 10966473. DOI: 10.1183/16000617.0137-2023. View

17.

Lareau S, Fahy B, Meek P, Wang A . Chronic Obstructive Pulmonary Disease (COPD). Am J Respir Crit Care Med. 2018; 199(1):P1-P2. DOI: 10.1164/rccm.1991P1. View

18.

Zipf G, Chiappa M, Porter K, Ostchega Y, Lewis B, Dostal J . National health and nutrition examination survey: plan and operations, 1999-2010. Vital Health Stat 1. 2014; (56):1-37. View

19.

Mannino D, Gagnon R, Petty T, Lydick E . Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160(11):1683-9. DOI: 10.1001/archinte.160.11.1683. View

20.

Borrud L, Chiappa M, Burt V, Gahche J, Zipf G, Johnson C . National Health and Nutrition Examination Survey: national youth fitness survey plan, operations, and analysis, 2012. Vital Health Stat 2. 2014; (163):1-24. View